Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
VANIW was delisted on the 8th of September, 2022.
4 hedge funds and large institutions have $14K invested in Vivani Medical, Inc. Warrants expiring 03/14/2024 in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
56% more capital invested
Capital invested by funds: $9K → $14K (+$5K)
33% more funds holding
Funds holding: 3 → 4 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.44K |
Top Sellers
VANIW Hedge Fund Activity: Q2 2022 in Review
4 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) for Q2 2022, worth a combined $14K — up 56% from $9K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new VANIW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $5.18K.
- 4 institutional investors held Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) as of Q2 2022, up from 3 in Q1 2022.
- Funds reported $14K of Vivani Medical, Inc. Warrants expiring 03/14/2024 stock for Q2 2022, up 56% quarter-over-quarter.
- 1 fund opened new Vivani Medical, Inc. Warrants expiring 03/14/2024 positions in Q2 2022 and 0 closed out, a net change of +1 holder.
- The largest Vivani Medical, Inc. Warrants expiring 03/14/2024 buyer in Q2 2022 was Susquehanna International Group, an estimated $5.18K added.
Based on aggregated 13F filings for Q2 2022.